Abstract
Although bilberry has been used for a variety of conditions, it has only been shown to be moderately effective in the treatment of retinopathy. No other clinical studies have demonstrated bilberry’s effectiveness for any other conditions. Fortunately, adverse effects from ingesting bilberry are minimal.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Cignarella A, Nastasi M, Cavalli E, Puglisi L. Novel lipid-lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate. Thromb Res 1996;84:311–322.
Muth ER, Laurent JM, Jasper P. The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity. Altern Med Rev 2000;5:164–173.
Monograph. Vaccinium myrtillus (bilberry). Altern Med Rev 2001;6:500–504.
Magistretti MJ, Conti M, Cristoni A. Antiulcer activity of an anthocyanidin from Vaccinium myrtillus. Arzneimittelforschung 1988;38:686–690.
Cristoni A, Magistretti MJ. Antiulcer and healing activity of Vaccinium myrtillus anthocyanosides. Farmaco [Prat] 1987;42:29–33.
Bonati A. How and why should we standardize phytopharmaceutical drugs for clinical validation? J Ethnopharmacol 1991;32:195–197.
Detre Z, Jellinek H, Miskulin M, Robert AM. Studies on vascular permeability in hypertension: action of anthocyanosides. Clin Physiol Biochem 1986;4:143–149.
Roy S, Khanna S, Alessio HM, et al. Anti-angiogenic property of edible berries. Free Radic Res 2002;36:1023–1031.
Laplaud PM, Lelubre A, Chapman MJ. Antioxidant action of Vaccinium myrtillus extract on human low density lipoproteins in vitro: initial observations. Fundam Clin Pharmacol 1997; 11:35–40.
Scharrer A, Ober M. [Anthocyanosides in the treatment of retinopathies (author’s translation)]. Klin Monatsbl Augenheilkd 1981; 178:386–389.
Perossini M, Guidi G, Chiellini S, Siravo D. Diabetic and hypertensive retinopathy therapy with Vaccinium myrtillus anthocyanosides (Tegens) double blind placebocontrolled clinical trial. Ann Ottalmol Clin Ocul 1987; 113:1173–1190.
Zadok D, Levy Y, Glovinsky Y. The effect of anthocyanosides in a multiple oral dose on night vision. Eye 1999;13(Pt 6):734–736.
Belleoud L, Leluan D, Boyer Y. Study on the effects of anthocyanin glycosides on the nocturnal vision of air traffic controllers. Rev Med Aeronaut Spatiale 1966; 18:3–7.
Jayle GE, Aubert L. Action des glucosides d’anthocyanes sur la vision scotopique et mesopique du subjet normal. Therapie 1964;19:171–185.
Terrasse J, Moinade S. Premiers reultats obtenus avec un nouveau facteur vitaminique P „les anthocanosides“ extraits du Vaccinium myrtillus. Press Med 1964;72:397–400.
Gloria E, Peria A. Effect of anthocyanosides on the absolute visual threshold. Ann Ottalmol Clin Ocul 1966;92:595–607.
Junemann G. [On the effect of anthocyanosides on hemeralopia following quinine poisoning]. Klin Monatsbl Augenheilkd 1967;151:891–896.
Caselli L. Clinical and electroretinographic study on activity of anthocyanosides. Arch Med Intern 1985;37:29–35.
Head KA. Natural therapies for ocular disorders, part two: cataracts and glaucoma. Altern Med Rev 2001;6:141–166.
Bravetti G. Preventive medical treatment of senile cataract with vitamin E and anthocyanosides: clinical evaluation. Ann Opthalmol Clin Ocul 1989; 115:109–116.
Saija A, Princi P, D’Amico N, De Pasquale R, Costa G. Effect of Vaccinium myrtillus anthocyanins on triiodothyronine transport into brain in the rat. Pharmacol Rev 1990;22:59–60.
Mazza G, Kay CD, Cottrell T, Holub BJ. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agric Food Chem 2002;50:7731–7737.
Cao G, Muccitelli HU, Sanchez-Moreno C, Prior RL Anthocyanins are absorbed in glycated forms in elderly women: a pharmacokinetic study. Am J Clin Nutr 2001;73:920–926.
Bitsch I, Janssen M, Netzel M, Strass G, Frank T. Bioavailability of anthocyanidin-3-glycosides following consumption of elderberry extract and blackcurrant juice. Int J Clin Pharmacol Ther 2004;42:293–300.
Morazzoni P, Bombardelli E, Vaccinium myrtillus L. Fitoterapia 1996;68:3–29.
FDA. Bilberry. In: Center for Food Safety and Applied Nutrition OoPAEAfad, 2004. Available at http://www.cfsan.fda.gov/~comm/ds-econ4.html. Last accessed: Sept. 2006.
Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines (translated by S. Klein). Austin American Botanical Council Boston, 1998.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this chapter
Cite this chapter
Tracy, T.S. (2007). Bilberry. In: Tracy, T.S., Kingston, R.L. (eds) Herbal Products. Forensic Science and Medicine. Humana Press. https://doi.org/10.1007/978-1-59745-383-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-59745-383-7_17
Publisher Name: Humana Press
Print ISBN: 978-1-58829-313-8
Online ISBN: 978-1-59745-383-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)